The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...

Folks over at Centra's Pearson Regional Cancer Center are bringing their patients and the Lynchburg community some holiday ...

PHILADELPHIA, PA — The Wistar Institute, led by Dr. David B. Weiner, has announced successful preclinical tests of a ...

A recently published study led by Wayne State University on a new approach to understanding chronic inflammation could lead to new advancements in the treatment of many debilitating medical conditions ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

Overall, the median real world time on treatment for earliest olaparib monotherapy 4.6 months (95% CI 3.5 - 5.5), for patients with less than 3 lines of therapy was 5.3 months (95% CI 4.0 – 8.2), and ...

Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease progression after chemotherapy and radiation.

The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...

Objective Colorectal cancer is primarily treated with surgery. Major surgery and older age are risk factors associated with postoperative decline in cognitive function. In clinical research, a wide ...

Rhode Island ranked second for its lung cancer survival rate, with more than 35% living five years post diagnosis. The state ...

The systemic agent is the first approved by the FDA for patients with NSCLC or pancreatic adenocarcinoma harboring an NRG1 gene fusion.

In one magical moment on Wednesday, Santa Claus worked with Princess Elsa of "Frozen" films to deliver a glorious wish to ...